-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

902. Health Services and Quality Improvement - Lymphoid Malignancies: Poster II

Symposia: Health Services and Quality Improvement - Lymphoid Malignancies Program: Oral and Poster Abstracts
Type: Poster
Sunday, December 10, 2023: 6:00 PM-8:00 PM
Halls G-H (San Diego Convention Center)

Maria Queralt Salas1*, Maria Teresa Solano1*, Mónica Baile González2*, Marina Acera Gómez2*, Maria Laura Fox, MD3*, Maria del Mar Pérez Artigas3*, Ana Santamaria4*, María del Carmen Quintela González4*, Andres Sanchez Salinas5*, Joaquina Salmeron Camacho5*, Veronica Illana Álvaro6*, Zahra Abdallahi Lefdil6*, Javier Cornago7*, Laura Pardo7*, Sara Fernandez-Luis8*, Leddy Patricia Vega Suárez8*, Sara Villar9*, Patricia Beorlegui Murillo10*, Albert Esquirol11*, Isabel Izquierdo12*, Sonia González Rodriguez13*, Alberto Mussetti, MD13*, Aitor Abuin Blanco14*, Javier López Marin15*, Silvia Filaferro16*, Leyre Bento17* and Anna Maria Sureda Balari, MD, PhD18

1Hematopoietic Cell Transplantation Unit, Hospital Clínic de Barcelona, ICHMO, Barcelona, Spain
2Servicio de Hematología y Hemoterapia del Complejo Asistencial Universitario de Salamanca -IBSAL, Salamanca, Spain
3Vall d'Hebron University Hospital, Barcelona, Spain
4Hospital Álvaro Cunqueiro, Vigo, Spain
5Hospital Universitario Virgen de la Arrixaca., Murcia, Spain
6Hospital Universitario de la Princesa, Madrid, Spain
7Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain
8Hospital Universitario Marqués de Valdecilla (IDIVAL), Santander, Spain
9Hematology and Cell Therapy Department, Clinica Universidad de Navarra, IdiSNA, Pamplona, Spain
10Hematology and Cell Therapy Department, Clinica Universidad de Navarra, Navarra, Spain
11Hematology Departmen, Hospital de Sant Pau, Barcelona, Spain
12Hospital Universitario Miguel Servet, Zaragoza, Spain
13Institut Catala d’Oncologia-Hospitalet, Clinical Hematology Department, Barcelona, Spain
14Servicio de Hematología. Hospital Universitario Lucus Augusti, Lugo, Spain
15Hospital General de Alicante, Alicante, Spain
16Grupo Español de Trasplante de Progenitores Hematopoyéticos y Terapia Celular (GETH-TC) Data Office, Madrid, Spain
17Hematology Department, Hospital Universitario Son Espases, IdISBa, Palma De Mallorca, Spain
18Clinical Hematology Department, Institut Català d’Oncologia-Hospitalet, IDIBELL, Barcelona, Spain

Zahra Mahmoudjafari, PharmD1*, Danilo Di Maio, PhD2*, Jia Li, PhD3*, Katherine L. Rosettie, MPH3* and Anthony Masaquel, PhD MPH3*

1The University of Kansas Health System, Kansas City, KS
2F. Hoffmann-La Roche Ltd, Basel, Switzerland
3Genentech, Inc., South San Francisco, CA

Tarun Bhagnani, MS, BPharm1*, Michael Roth, MD2, Kristen M. O'Dwyer, MD3, Julie Wolfson, MD, MSHS4, Indrani Chatterjee, PhD1*, Arun Prashar, MD1*, Ravi Potluri, MBA5*, Eros Papademetriou, MA5*, Robert Paglia, MBA, RPh1* and David Robert Freyer, DO6*

1Servier Pharmaceuticals LLC, Boston, MA
2Department of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, TX
3University of Rochester Medical Center, Rochester, NY
4The University of Alabama at Birmingham, Birmingham, AL
5Putnam PHMR, New York, NY
6Children's Hospital Los Angeles, Los Angeles, CA

Manali K. Kamdar, MD, MBBS1, Ellie Moses-Okwei, PhD2*, Shelby Sullivan, PharmD3*, Jeffrey Carter, PhD2* and Cherilyn Heggen, PhD2*

1University of Colorado,, Denver, CO
2PRIME Education, LLC, Fort Lauderdale, FL
3PRIME Education, LLC, Berkley, MI

Arliene Ravelo, MPH1*, Kelley Myers, PhD2*, Claire Ervin, MPH2*, Robyn Brumble, MSN, RN3*, Cooper Bussberg2*, Brian Koffman, MD3, Beenish S Manzoor, PhD, MPH4*, Juliana M. L. Biondo, MD1 and Carol Mansfield, PhD2*

1Genentech Inc., South San Francisco, CA
2RTI Health Solutions, Research Triangle Park, NC
3CLL Society, Chula Vista, CA
4AbbVie, North Chicago, IL

Anna J Howard, RN1*, Tala Shekarkhand, MS2*, Issam S. Hamadeh, Pharm.D.3*, Alice Wang, Pharm.D.3*, Dhwani Patel, MD2*, Carlyn Tan, MD2, Malin Hultcrantz, MD, PhD2, Sham Mailankody, MBBS2, Hani Hassoun, MD2, Urvi A Shah, MD2, Neha Korde, MD2, Kylee H Maclachlan, MBChB, PhD2, Heather Landau, MD4, Michael Scordo5, Gunjan L. Shah, MD5*, Oscar Boutros Lahoud4, Sergio A. Giralt, MD, FACP6, David Chung, MD, PhD5, Alexander Lesokhin, MD2, Saad Z Usmani, MD5 and Ross Firestone, MD, PhD7

1Multiple Myeloma Service, Memorial Sloan Kettering Cancer Center, New York, NY
2Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
3Pharmacy, Memorial Sloan Kettering Cancer Center, New York, NY
4Adult Bone Marrow Transplant Service, Division of Hematologic Oncology, Memorial Sloan Kettering Cancer Center, New York, NY
5Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
6Weill Cornell Medical College, Memorial Sloan Kettering Cancer Center, New York, NY
7Myeloma Service, Division of Hematologic Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY

Brooj Abro, MD1*, Matthew J. Maurer, DSc2, Thomas M. Habermann, MD3, Richard Burack, MD, PhD4, Jennifer R. Chapman-Fredricks, MD5*, Jonathon B. Cohen, MD, MS6, Jonathan W. Friedberg, MD, MMSc7, Giorgio Inghirami, MD8*, Brad S. Kahl, MD9, Melissa C. Larson, MS10*, Brian K. Link, MD11*, Izidore S. Lossos, MD12,13, Peter Martin, MD14, Timothy J. McDonnell, MD, PhD15*, Loretta J. Nastoupil, MD16, Shaun M. Riska17*, Sergei Syrbu, MD, PhD18*, Francisco Vega, MD, PhD19, Kiran R. Vij20, Christopher R. Flowers, MD, MS21, James R. Cerhan, MD, PhD22, David L Jaye, MD23 and Andrew L. Feldman, MD24

1Emory University School of Medicine, Atlanta, GA
2Department of Health Sciences Research, Mayo Clinic, Rochester, MN
3Division of Hematology, Mayo Clinic, Rochester, MN
4University of Rochester, Rochester, NY
5University of Miami Miller School of Medicine, Miami, FL
6Winship Cancer Institute, Emory University, Atlanta, GA
7Wilmot Cancer Center, University of Rochester, Rochester, NY
8Weill Cornell Medicine, New York, NY
9Siteman Cancer Center, Division of Oncology, Washington University School of Medicine in St. Louis, Saint Louis, MO
10Department of Quantitative Health Sciences, Mayo Clinic College of Medicine, Rochester, MN
11Division of Hematology, Oncology, and Blood & Marrow Transplantation, University of Iowa Hospitals and Clinics, Iowa City, IA
12University of Miami - Miller School of Medicine, Miami, FL
13Sylvester Comprehensive Cancer Center, Division of Hematology, University of Miami School of Medicine, Miami, FL
14Weill Cornell Medicine, New York
15UT M.D. Anderson Cancer Center, Houston, TX
16MD Anderson Cancer Center, Houston, TX
17Mayo Clinic College of Medicine, Rochester, MN
18University of Iowa, Iowa City, IA
19Department of Hematopathology, MD Anderson Cancer Center , Houston, TX
20Washington University School of Medicine, Saint Louis, MO
21Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
22Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN
23Department of Pathology and Laboratory Medicine, Emory University, Atlanta, GA
24Department of Laboratory Medicine and Pathology, Division of Hematopathology, Mayo Clinic, Rochester, MN

Benjamin Chin-Yee, MD, MA1,2*, Tiancheng Hu, MSc^3*, Clarissa Skorupski, MD4*, Sarah Ghnaim, MD5*, Bishal Gyawali, PhD, MD6*, Turab Mohammed, MD7*, James Yu, MD8*, Gary H. Lyman, MD9,10, Michelle Sholzberg, MD11,12, Lisa Hicks, MD11,12 and Nicole M. Kuderer, MD, MSc#13

1Division of Hematology, Department of Medicine, Western University, London, ON, Canada
2Department of History and Philosophy of Science, University of Cambridge, Cambridge, United Kingdom
3Language Technology Lab, Department of Theoretical and Applied Linguistics, University of Cambridge, Cambridge, United Kingdom
4Department of Medicine, University of Toronto, Toronto, ON, CAN
5Department of Medicine, Western University, London, Canada
6Department of Oncology, Queen's University, Kingston, Canada
7Moffit Cancer Center, Tampa, FL
8Division of Hematology and Medical Oncology, H. Lee Moffit Cancer Center, Tampa, FL
9Fred Hutchinson Cancer Center, Seattle, WA
10Department of Medicine, University of Washington School of Medicine, Seattle, WA
11Li Ka Shing Knowledge Institute, University of Toronto, Toronto, ON, Canada
12Division of Hematology-Oncology, St. Michael's Hospital, Toronto, ON, Canada
13Advanced Cancer Research Group, Seattle, WA

Manju Sengar, MD, DM1, Tanuja Shet, MBBS, MD, DPB, DNB, DTM2*, Papagudi Ganesan Subramanian, MD3* and Prashant Tembhare, MD, DM3*

1Department of Medical Oncology, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, India
2Department of Pathology, Tata Memorial Centre, Mumbai, India
3Department of Hemato Pathology, Tata Memorial Centre, Mumbai, India

Mythri Mudireddy1, Erik Dvergsten2*, Sanja Karovic2*, Chiara Pierattini2*, Kathryn M Cappell, MD, PhD3 and Ashley E Hanlon, MD1

1Inova Schar Cancer Institute, Fairfax, VA
2Data Analytics Core Facility, Inova Fairfax Medical Center, Fairfax, VA
3Surgery Branch, National Cancer Institute, Bethesda, MD

Sikander Ailawadhi1, November McGarvey2*, Ken Imanak, PhD2*, Sana Mirza2* and Pallavi Patwardhan, PhD, BSPharm3*

1Mayo Clinic, Jacksonville, FL
2BluePath Solutions, Los Angeles, CA
3Bristol Myers Squibb, Princeton, NJ

Caitlyn Duffy, MD, MPH1*, Zehra Fadoo, MBBS, MD2*, Niharendu Ghara, MBBS, MD3*, Victor Santana, MD1*, Hiroto Inaba, MD, PhD4, Sima Jeha, MD5, Yichen Chen6*, Linh Pham6*, Hyun Jy Chung6*, Meenakshi Devidas, PhD, MBA7, Nickhill Bhakta, MD, MPH5* and Heather Brandt, PhD6*

1St. Jude Children's Research Hospital, Memphis, TN
2Aga Khan University Hospital, Karachi, Pakistan
3Tata Medical Center, Kolkata, India
4Department of Oncology, St. Jude Children's Research Hospital, Memphis, TN
5Department of Global Pediatric Medicine, St. Jude Children's Research Hospital, Memphis, TN
6St. Jude Children's Research Hospital, Memphis
7St Jude Children's Research Hospital, Memphis, TN

Fabio Efficace, PhD1*, Mario Luppi, MD2*, Leonardo Potenza, MD, PhD3*, Francesco Sparano1*, Giovanni Caocci, MD4, Francesca Fazio5*, Massimo Breccia5*, Maria Teresa Petrucci5*, Andrea Patriarca, MD6*, Thomas Baldi1*, Michelina Santopietro, MD7*, Roberta Battistini7*, Agostino Tafuri, MD8, Gloria Margiotta Casaluci, MD6*, Elisabetta Colaci2*, Davide Giusti2*, Valeria Pioli2*, Paolo De Fabritiis, MD9*, Nicolina Rita Ardu9*, Pasquale Niscola, MD9*, Olga Mulas, MD4*, Claudio Fozza, MD10*, Sergio Siragusa11*, Salvatrice Mancuso11*, Paola Boggione6*, Lorenzo De Paoli6*, Anna Paola Leporace8*, Maria Paola Bianchi8*, Ida Carmosino, MD5*, Claudio Cartoni5*, Alice Di Rocco5*, Isabella Capodanno, MD12*, Massimo Pini13*, Alessandra Romano, MD14*, Paola Fazi, MD1* and Marco Vignetti, MD1*

1Italian Group for Adult Hematologic Diseases (GIMEMA), Data Center and Health Outcomes Research Unit, Rome, Italy
2Hematology Unit and Chair, Azienda Ospedaliera Universitaria di Modena, Department of Medical and Surgical Sciences, University of Modena and Reggio Emilia, Modena, Italy
3Hematology Unit and Chair, Department of Medical and Surgical Sciences, Azienda Ospedaliera Universitaria di Modena, University of Modena and Reggio Emilia, Modena, Italy
4Department of Medical Sciences and Public Health, University of Cagliari, Businco Hospital, Cagliari, Italy
5Hematology, Department of Translational and Precision Medicine, Azienda Ospedaliera Policlinico Umberto I, Sapienza University of Rome, Rome, Italy
6Division of Hematology, Department of Translational Medicine, University of Eastern Piedmont, Novara, Italy
7Hematology and Hematopoietic Stem Cells Transplant Unit, AO San Camillo-Forlanini, Rome, Italy
8Azienda Ospedaliera Sant'Andrea, Rome, Italy
9Hematology Unit, Sant'Eugenio Hospital, Rome, Italy
10Department of Medicine, Surgery and Pharmacy, University of Sassari, Sassari, Italy
11Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties, University of Palermo, Palermo, Italy
12Hematology Unit, Azienda Unità Sanitaria Locale-IRCCS, Reggio Emilia, Italy
13Hematology and Thrombotic Diseases, San Giovanni Bosco Hospital, Turin, Italy
14Division of Hematology, Azienda Policlinico-S. Marco, University of Catania, Catania, Italy

Carmine Deluca1*, Michael Beyer2*, Heather Drew3*, Jeffrey Murray, PhD4*, Jessica Massey, MD2*, Brian Koffman, MD5, Kristen Battiato, MSN, RN, AGNP-C6*, John G. Gribben, MD, DSc7, Nicole Lamanna, MD8 and Christina Russomanno, RN, MS, NP-C9*

1PeerView Institute for Medical Education, Silver Spring, MD
2PeerView Institute for Medical Education, New York, NY
3PeerView Institute for Medical Education, Hewitt, NJ
4PeerView Institute for Medical Education, Suwanee, GA
5CLL Society, Chula Vista, CA
6Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, NY
7Barts Cancer Institute, Queen Mary University of London, London, United Kingdom
8Herbert Irving Comprehensive Cancer Center, New York-Presbyterian/Columbia University Medical Center, New York, NY
9Leukemia Service, Herbert Irving Comprehensive Cancer Center, New York, NY

Ryan P. Topping1*, Timothy A. Quill, PhD2*, Nicole Lamanna, MD3 and Jeff P. Sharman, MD4

1Clinical Care Options, Whitsett, NC
2Clinical Care Options, Reston, VA
3New York-Presbyterian Columbia University Medical Center, New York, NY
4US Oncology Research, Willamette Valley Cancer Institute and Research Center, Eugene, OR

November McGarvey1*, Matthew Gitlin1*, Abraham Lee1*, Scott J. Keating2*, Victoria Barghout3* and Simran K. Tiwana2*

1BluePath Solutions, Los Angeles, CA
2Bristol Myers Squibb, Princeton, NJ
3VEB HealthCare LLC, Morristown, NJ

Janelle Soong, MRPharmS1*, Giuseppe De Carlo1*, Naziah Lasi-Tejani, MS2*, Sumanjit K. Sethi, PhD1*, Natacha Bolaños3*, Martine Elias4*, Yelak Biru5*, Solène Clavreul, PhD6*, G. Scott Chandler, MD1*, Klaus Finzler, MD1*, Yann Nouet, PhD MSc1 and Antonio Giuseppe Del Santo, MD1

1F. Hoffmann-La Roche Ltd, Basel, Switzerland
2Genentech, Inc., South San Francisco, CA
3Lymphoma Coalition, Mississauga, ON, Canada
4Myeloma Canada, Dorval, QC, Canada
5International Myeloma Foundation, Studio City, CA
6Myeloma Patients Europe, Brussels, Belgium

Sandra Mazzoni, DO1, Jack Khouri, MD2, Louis S. Williams, MD3, Beth M. Faiman, PhD, CNP2, Saveta Mathur, CNP4* and Cynthia Scott, CNP2*

1Department of Hematology and Medical Oncology, Taussig Cancer Center, Cleveland Clinic, Cleveland, OH
2Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH
3Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH
4Cleveland Clinic Taussig Cancer Institute, Cleveland, OH

*signifies non-member of ASH